Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Prentice

Showing results (101-110 of 299) with videos related to

Pageof 30
Sort By:
Clinical and Experimental Immunology|December 12, 2001
Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemiaJ K Orleans-Lindsay, L D Barber, H G Prentice, et al.
British Medical Journal (Clinical Research Ed.)|March 6, 1982
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemiaD B Freedman, M Shannon, P Dandona, et al.
Experimental Hematology|December 1, 1995
VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantationM W Lowdell, F Shamim, M Hamon, et al.
Bone Marrow Transplantation|May 13, 1998
The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemiaM W Lowdell, R Craston, N Ray, et al.
Clinical and Experimental Immunology|March 1, 1992
IL-2 infusion abrogates humoral immune responses in humansD J Gottlieb, H G Prentice, H E Heslop, et al.
British Journal of Haematology|February 13, 2001
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patientsP J Paterson, P H McWhinney, M Potter, et al.
Bone Marrow Transplantation|November 1, 1993
Value of routine surveillance cultures for detection of CMV pneumonitis following bone marrow transplantationA Webster, B Blizzard, D Pillay, et al.
Bone Marrow Transplantation|March 1, 1995
Granisetron in the prevention of irradiation-induced emesisH G Prentice, S Cunningham, L Gandhi, et al.
British Journal of Cancer|December 1, 1984
Intravenous and hepatic arterial infusion of high dose mitomycin C with autologous bone marrow transplantation in patients with tumour metastatic to the liverR E Corringham, R Dick, M J Gilmore, et al.
Cancer|April 1, 1984
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's diseaseT de Witte, H A Blacklock, H G Prentice, et al.
Pageof 30

Showing results (101-110 of 299) with videos related to

Sort By:
Pageof 30
Clinical and Experimental Immunology|December 12, 2001
Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemiaJ K Orleans-Lindsay, L D Barber, H G Prentice, et al.
British Medical Journal (Clinical Research Ed.)|March 6, 1982
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemiaD B Freedman, M Shannon, P Dandona, et al.
Experimental Hematology|December 1, 1995
VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantationM W Lowdell, F Shamim, M Hamon, et al.
Bone Marrow Transplantation|May 13, 1998
The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemiaM W Lowdell, R Craston, N Ray, et al.
Clinical and Experimental Immunology|March 1, 1992
IL-2 infusion abrogates humoral immune responses in humansD J Gottlieb, H G Prentice, H E Heslop, et al.
British Journal of Haematology|February 13, 2001
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patientsP J Paterson, P H McWhinney, M Potter, et al.
Bone Marrow Transplantation|November 1, 1993
Value of routine surveillance cultures for detection of CMV pneumonitis following bone marrow transplantationA Webster, B Blizzard, D Pillay, et al.
Bone Marrow Transplantation|March 1, 1995
Granisetron in the prevention of irradiation-induced emesisH G Prentice, S Cunningham, L Gandhi, et al.
British Journal of Cancer|December 1, 1984
Intravenous and hepatic arterial infusion of high dose mitomycin C with autologous bone marrow transplantation in patients with tumour metastatic to the liverR E Corringham, R Dick, M J Gilmore, et al.
Cancer|April 1, 1984
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's diseaseT de Witte, H A Blacklock, H G Prentice, et al.
Pageof 30